Neomycin and carbodiimide crosslinking as an alternative to glutaraldehyde for enhanced durability of bioprosthetic heart valves. (May 2013)

• Record Type: Journal Article
• Authors: Leong, Joshua; Munnelly, Amy; Liberio, Brianna; Cochrane, Leonard; Vyavahare, Naren
• Is Part Of: Journal of biomaterials applications. Volume 27:Number 8(2013)
• Page Start: 948
• Page End: 960
• Publication Date: 2013-05
• Subjects: Porcine aortic heart valve -- alternative cross-linking -- glycosaminoglycan -- valve durability -- calcification; Biomedical engineering -- Periodicals; Biomedical materials -- Periodicals; 610.28
• DOI: 10.1177/0885328211430542
• Languages: English
• ISSNs: 0885-3282

Abstract

Glutaraldehyde cross-linked porcine aortic valves, referred to as bioprosthetic heart valves (BHVs), are often used in heart valve replacements. Glutaraldehyde does not stabilize glycosaminoglycans (GAGs) and they are lost during preparation, in vivo implantation, cyclic fatigue, and storage. We report that binding of neomycin, a hyaluronidase inhibitor, to the tissues with carbodiimide cross-linking improves GAG retention without reducing collagen and elastin stability. It also led to improved biomechanical properties. Neomycin carbodiimide cross-linking did not significantly reduce calcification in a rat subdermal implantation model when they were stored in formaldehyde after cross-linking. Removal of formaldehyde storage significantly reduced calcification.